Form 4: Oncocyte Corp Director Andrew Arno Acquires 12,500 Shares

Director Andrew Arno of Oncocyte Corp purchased 12,500 shares of common stock at an average price of $2.108 per share on December 26, 2024.

Summary

• On December 26, 2024, Andrew Arno, a director at Oncocyte Corp, acquired 12,500 shares of the company's common stock.
• The shares were purchased at a weighted average price of $2.108 per share, with individual prices ranging from $2.1000 to $2.1300.
• Following the transaction, Mr. Arno directly owns 81,554 shares of Oncocyte Corp.
• Additionally, Mr. Arno indirectly controls 7,804 shares through JBA Investments LLC and another 7,804 shares through MJA Investments LLC, where he serves as the manager.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock purchase by a director. It is neither overwhelmingly positive nor negative, but the purchase could be interpreted as a sign of confidence.

Positives

• The purchase of shares by a director can be seen as a positive sign of confidence in the company's future prospects.
• The director's increased stake in the company aligns his interests with those of other shareholders.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The transaction is typical for directors who may buy or sell shares in their company, and the reporting is consistent with SEC regulations.
• Similar filings can be seen across all publicly listed companies in the US.

Stakeholder Impact

• The stock purchase by a director may positively influence investor sentiment.
• The increased ownership by a director aligns his interests with those of other shareholders.

Key Dates

Keywords

Oncocyte Corp, insider trading, Form 4, stock purchase, Andrew Arno, director, share acquisition, JBA Investments LLC, MJA Investments LLC